Michael Alfieri
CIK: 0001744687
Transaction Breakdown
Open Market Buys (P)2 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALDX
Aldeyra Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Alfieri Michael
Alfieri Michael (SEC CIK 0001744687) files insider reports with the SEC as Principal Financial Officer of Aldeyra Therapeutics, Inc. (ALDX).
Signal8 holds 3 ownership filings by Alfieri Michael (1 Form 3, 2 Form 4), filed between Sep 10, 2024 and Mar 19, 2026. Those filings report 2 transactions, from Aug 13, 2025 to Mar 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Alfieri Michael's filings is in LEXINGTON, MA.
Recent filings by Alfieri Michael
Other insiders filing for Aldeyra Therapeutics, Inc. (ALDX)
- Miller-Rich Nancy, Director
- DOUGLAS RICHARD, Director
- Phillips Gary M., Director
- Clark William D, Director
- Walker Neal, Director
- Bronstein Ben, Director